CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 28 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $426 | -39.7% | 1,200 | 0.0% | 0.00% | – |
| Q2 2023 | $707 | +3.2% | 1,200 | 0.0% | 0.00% | – |
| Q1 2023 | $685 | -15.2% | 1,200 | -1.0% | 0.00% | – |
| Q4 2022 | $808 | -59.6% | 1,212 | +1.0% | 0.00% | – |
| Q3 2022 | $2,000 | -98.5% | 1,200 | -96.4% | 0.00% | – |
| Q4 2021 | $131,000 | -77.8% | 33,762 | -69.9% | 0.00% | – |
| Q3 2021 | $591,000 | -17.7% | 112,221 | -7.5% | 0.00% | – |
| Q2 2021 | $718,000 | +1.0% | 121,275 | +21.3% | 0.00% | – |
| Q1 2021 | $711,000 | -20.8% | 100,000 | -13.0% | 0.00% | – |
| Q4 2020 | $898,000 | +44800.0% | 115,000 | +28650.0% | 0.00% | – |
| Q2 2020 | $2,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 462,659 | $1,411,000 | 0.58% |
| Sio Capital Management, LLC | 422,598 | $1,289,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 508,322 | $1,550,000 | 0.22% |
| Affinity Asset Advisors, LLC | 400,000 | $1,220,000 | 0.20% |
| Atom Investors LP | 31,385 | $96,000 | 0.04% |
| Ikarian Capital, LLC | 104,741 | $319,000 | 0.04% |
| Schonfeld Strategic Advisors LLC | 514,780 | $1,570,000 | 0.01% |
| PURA VIDA INVESTMENTS, LLC | 77,568 | $237,000 | 0.01% |
| Point72 Asset Management, L.P. | 230,000 | $702,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 58,934 | $179,000 | 0.00% |